Review Article

Safety and Efficacy of Treatment with/without Ramucirumab in Advanced or Metastatic Cancer: A Meta-Analysis of 11 Global, Double-Blind, Phase 3 Randomized Controlled Trials

Table 4

Meta analysis of TEAEs.

TEAEsStudies, nRAM, nCon, nOR (95% CI) value
EventsTotalEventsTotal

Fatigue9
 Grade 1-216863526126929231.14 [1.03, 1.27]0.01
 Grade ≧3383352622429231.44 [1.21, 1.71]<0.00001

Hypertension5
 Grade 1-217414226312792.55 [1.89, 3.44]<0.00001
 Grade ≧313114222912794.25 [1.57, 11.53]0.004

Neuropathy4
 Grade 1-2349174132017401.12 [0.94, 1.33]0.21
 Grade≧34917413017401.66 [1.05, 2.62]0.03

Decreased appetite11
 Grade 1-21098404074332931.34 [1.20, 1.50]<0.00001
 Grade≧314340405532932.10 [1.52, 2.90]<0.00001

Abdominal pain9
 Grade 1-2546306745126861.06 [0.82, 1.37]0.65
 Grade ≧38930676926861.13 [0.82, 1.56]0.45

Nausea9
 Grade 1-2966305285027961.13 [1.01, 1.27]0.04
 Grade ≧35230526127960.84 [0.57, 1.22]0.36

Alopecia6
 Grade 1-2643225562621100.94 [0.71, 1.24]0.66
 Grade ≧303782030280.34 [0.04, 3.26]0.35

Diarrhoea9
 Grade 1-2887305282327961.11 [0.86, 1.44]0.41
 Grade ≧3144305210727961.52 [0.95, 2.43]0.08

Epistaxis6
 Grade 1-2596212815116223.58 [2.94, 4.36]<0.00001
 Grade ≧312128316221.53 [0.06, 37.57]0.80

Vomiting9
 Grade 1-2593306749526861.09 [0.95, 1.25]0.21
 Grade≧37030678026860.78 [0.56, 1.08]0.13

Peripheral oedema5
 Grade 1-2433195720618462.28 [1.90, 2.73]<0.00001
 Grade ≧3101957318462.37 [0.74, 7.58]0.15

Constipation8
 Grade 1-2481274441423711.01 [0.87, 1.17]0.89
 Grade ≧3927442023710.41 [0.19, 0.88]0.02

Stomatitis6
 Grade 1-2871271442023472.00 [1.57, 2.54]<0.00001
 Grade≧310827143123472.92 [1.94, 4.40]<0.00001

Pyrexia8
 Grade 1-2427272926524811.55 [1.32, 1.83]<0.00001
 Grade ≧3112729724811.41 [0.57, 3.48]0.45

Proteinuria5
 Grade 1-227013769012402.89 [1.98, 4.21]<0.00001
 Grade ≧3241376212406.26 [2.05, 19.10]0.001

Dyspnoea6
 Grade 1-2251217424519500.96 [0.79, 1.16]0.65
 Grade ≧34421746719500.82 [0.32, 2.09]0.68

Rash4
 Grade 1-2137133513113471.06 [0.82, 1.37]0.65
 Grade ≧331335813470.45 [0.14, 1.46]0.18

Weight decreased3
 Grade 1-281149510021.37 [0.49, 3.80]0.55
 Grade ≧3164114910610021.31 [0.83, 2.05]0.25

Cough6
 Grade 1-2356227426121211.37 [1.15, 1.63]0.0004
 Grade ≧352274721210.76 [0.27, 2.11]0.60

Back pain4
 Grade 1-214315051043571.24 [0.95, 1.62]0.12
 Grade ≧3121505713571.67 [0.67, 4.16]0.27

Hypoalbuminaemia3
 Grade 1-2150897567502.05 [1.47, 2.87]<0.0001
 Grade ≧3889747501.70 [0.54, 5.30]0.36

Myalgia2
 Grade 1-2495459470.81 [0.23, 2.82]0.74
 Grade ≧3112954769471.52 [1.12, 2.07]0.007

Ascites3
 Grade 1-2109801487002.20 [1.53, 3.16]<0.0001
 Grade≧333801267001.14 [0.67, 1.94]0.63

Headache5
 Grade 1-2252195714818461.98 [1.17, 3.35]0.01
 Grade ≧381957818460.93 [0.39, 2.22]0.87

Neutropenia6
 Grade 1-2724281659124371.16 [1.02, 1.33]0.03
 Grade ≧3858281657224371.67 [1.20, 2.33]0.002

Anaemia6
 Grade 1-2424230046921700.83 [0.71, 0.96]0.01
 Grade ≧3161259317923150.71 [0.56, 0.89]0.003

Leucopenia3
 Grade 1-2218127715312621.50 [1.20, 1.88]0.0004
 Grade ≧3190127711612621.69 [0.97, 2.94]0.06

Thrombocytopenia6
 Grade 1-2381234117523312.47 [2.04, 3.00]<0.00001
 Grade ≧37823412623313.02 [1.94, 4.72]<0.00001